RB51

Indications

• Medical abortion
• Management of incomplete miscarriage
• Management of missed abortion

Dosage

Children: Refer to clinical guidelines for specific dosing, as it varies based on regimen and clinical scenario.

Adults: Refer to clinical guidelines for specific dosing, as it varies based on regimen and clinical scenario.

Mechanism of action

Mifepristone, also known as RU-486, functions as a synthetic steroid that acts as an antagonist of progesterone receptors. By blocking the action of progesterone, mifepristone disrupts the uterine lining and sensitizes the uterus to prostaglandins. Misoprostol, a prostaglandin analog, induces uterine contractions and cervical ripening, facilitating the expulsion of the pregnancy tissue.

Pharmacodynamics

The pharmacodynamic effects of abortive agents include myometrial contractions, cervical dilation, and changes in the endometrial environment. These effects lead to the detachment of the embryo or fetus from the uterine wall and subsequent expulsion. Mifepristone's antagonistic action on progesterone contributes to the pharmacological cascade that results in uterine contractility and tissue breakdown.

Pharmacokinetics

Mifepristone is rapidly absorbed following oral administration, with peak plasma concentrations occurring within 1-2 hours. It undergoes extensive hepatic metabolism, primarily via cytochrome P450 3A4, and has a half-life of approximately 20-30 hours. Misoprostol is also well absorbed after oral administration, with peak plasma concentrations occurring within 30-120 minutes. Its half-life is short, around 20-40 minutes, and it is metabolized in the liver. Both drugs are excreted primarily in urine.

Contra-indications

• Known hypersensitivity to abortus or any of its components
• Pregnant women unless used for specific medical indications
• Severe cardiovascular disorders
• Severe liver or kidney impairment

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain or cramping
• Headache
• Dizziness
• Fatigue
• Fever
• Chills

Interactions

• Anticoagulants may have increased effects
• Corticosteroids may reduce therapeutic effects
• Other medications that affect liver enzymes can alter the metabolism

Precautions

• Monitor for signs of severe adverse reactions
• Caution in patients with a history of gastrointestinal disease
• Use cautiously in patients with renal or hepatic impairment
• Consider potential for drug interactions

Pregnancy

Abortus is contraindicated in pregnancy unless specifically indicated for medical reasons.

Breast-feeding

Use with caution, as it may be excreted in breast milk and affect the infant.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

• Oral tablets
• Injectable solution

Indications

• Brucellosis
• Undulant fever
• Osteoarticular infections
• Hepatosplenomegaly
• Pneumonia due to Brucella

Dosage

Children: Refer to established guidelines for paediatric dosing based on specific antibiotic therapy.

Adults: Refer to established guidelines for dosage based on specific antibiotic therapy.

Mechanism of action

Brucella species invade host cells, primarily macrophages, where they survive and replicate. They can evade the host immune response by interfering with phagosome-lysosome fusion, thus avoiding destruction. The antibiotics used to treat brucellosis, such as doxycycline and rifampin, target bacterial protein synthesis and cell wall synthesis, respectively, effectively killing the bacteria or inhibiting their growth.

Pharmacodynamics

The pharmacodynamics of antibiotics used against Brucella involve their bactericidal or bacteriostatic effects, depending on the drug class. Doxycycline, for instance, inhibits protein synthesis in bacteria by binding to the 30S ribosomal subunit, while rifampin inhibits bacterial RNA synthesis by binding to DNA-dependent RNA polymerase. The combination of antibiotics can enhance efficacy and reduce the risk of resistance development.

Pharmacokinetics

The pharmacokinetics of antibiotics for brucellosis vary. Doxycycline is well-absorbed orally, with peak plasma concentrations occurring within 2 hours. It is widely distributed in tissues and can penetrate well into various body compartments. Rifampin is also well absorbed, with peak concentrations reached within 2 to 4 hours after administration. It is extensively metabolized in the liver and has a long half-life, allowing for once-daily dosing in some cases.

Adverse effects

• Fever
• Sweating
• Fatigue
• Muscle pain
• Joint pain
• Headache
• Loss of appetite
• Weight loss
• Depression
• Potential for chronic infection

Precautions

• Use caution in individuals with compromised immune systems.
• Monitor for signs of chronic infection.
• Consider potential for zoonotic transmission in handling infected animals.

Pregnancy

Brucella infection during pregnancy can lead to complications including miscarriage, stillbirth, and preterm labor. Consultation with a healthcare provider is essential.

Breast-feeding

Brucella can be transmitted through breast milk; therefore, breastfeeding may need to be avoided if the mother is infected.

Storage

Store in a cool, dry place away from direct sunlight. Follow specific storage instructions for any medicinal formulations.

Indications

• Clinical term 1
• Common term 1
• Clinical term 2
• Common term 2

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidelines.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Dose acts by modulating the activity of specific neurotransmitter receptors and ion channels, influencing various physiological pathways. Its precise mechanism may involve interactions with G-protein coupled receptors, leading to downstream signaling effects that impact cellular responses.

Pharmacodynamics

Dose exhibits a range of effects depending on the dosage and target tissues. It is known to alter neurotransmitter release, affect ion conductance, and influence metabolic pathways, thereby contributing to its therapeutic efficacy and potential side effects.

Pharmacokinetics

Dose is generally absorbed following administration, with peak plasma concentrations occurring within a specified timeframe. Its distribution is influenced by tissue binding and permeability across cell membranes. The drug is metabolized primarily in the liver, with metabolites being excreted via renal and biliary routes. The half-life can vary based on individual patient factors, including age, liver function, and other concurrent medications.

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Prevention of infectious diseases such as measles, mumps, rubella, hepatitis B, influenza, and human papillomavirus (HPV)
• Travel vaccinations for diseases endemic to certain regions
• Vaccination for at-risk populations, such as those with compromised immune systems or specific occupational exposures

Dosage

Children: Dosage varies by vaccine type and age; refer to the BNF for Children for specific dosing information.

Adults: Dosage varies by vaccine type and indication; refer to specific guidelines for each vaccine.

Mechanism of action

Vaccines work by mimicking an infection. They introduce a harmless component of a pathogen (antigen) to the immune system, prompting the body to produce an immune response. This includes the generation of antibodies and memory cells that provide long-term immunity. Upon subsequent exposure to the actual pathogen, the immune system is primed to respond more rapidly and effectively.

Pharmacodynamics

The pharmacodynamics of vaccines involves the activation of both humoral and cellular immunity. Vaccines stimulate B cells to produce antibodies against the pathogen, while T cells are activated to destroy infected cells. This dual response helps to establish immunological memory, which enables a faster and more robust response upon re-exposure to the pathogen.

Pharmacokinetics

Vaccines are administered via various routes, including intramuscular, subcutaneous, and oral. After administration, the antigens are presented to antigen-presenting cells, which activate T cells and stimulate B cell proliferation and differentiation. The half-life of vaccine-induced immunity varies depending on the type of vaccine, with some providing lifelong immunity and others requiring booster doses to maintain protection.

Contra-indications

• Severe allergic reaction (anaphylaxis) to a component of the vaccine
• Severe immunocompromised state for live attenuated vaccines

Adverse effects

• Local reactions at the injection site (pain, redness, swelling)
• Fever
• Fatigue
• Headache
• Muscle pain
• Joint pain
• Nausea

Interactions

• Immunosuppressive medications may reduce vaccine efficacy
• Concurrent administration of some vaccines may require spacing to optimize immune response

Precautions

• History of allergic reactions to vaccines or vaccine components
• Pregnancy (specific vaccines may be contraindicated)
• Moderate to severe acute illness with or without fever

Pregnancy

Consult healthcare provider. Some vaccines are contraindicated during pregnancy, while others are recommended.

Breast-feeding

Generally considered safe, but consult healthcare provider regarding specific vaccines.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Liquid suspension for injection
• Lyophilized powder for reconstitution